HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

January 4, 2024

Study Completion Date

January 4, 2024

Conditions
HIVAlcohol Use
Interventions
BEHAVIORAL

IMB-motivational interviewing (MI) techniques (IMB-MI)

The clinical pharmacist will employ MI in informational, participant-centered discussions in which the clinical pharmacist and participant collaboratively discuss the harms of drinking and polypharmacy (specifically alcohol interactive medications), symptoms associated with alcohol and specific medications, and how to mitigate these harms. Motivational elements include messages highlighting the participant's personal risk of bothersome symptoms from their use of alcohol and level of polypharmacy, attitude change elements to improve attitudes toward the intended behavior change, social normative support for the intended behavior change including identification of people who can support the participant in this process, and a menu of options for referrals for skill building (e.g. Social Work, meeting with the clinical pharmacist at their clinic, follow-up with the HIV clinician, alcohol-reduction programs, based on what is locally available as part of VA-based care).

Trial Locations (1)

06516

West Haven CT Veterans Administration, West Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER